This content is intended for Healthcare Professionals only. If you're not a Healthcare Professional, please consult your doctor about the risks and benefits of surgery.

Clinical Papers

Australian Biotechnologies is an innovative and progressive company focusing on improving the quality of Allograft products available to the Australian market.

Allovance® Crunch is processed with NanoXpose technology to produce a 100% natural, nano surface exposed, Australian made allograft that is used diversely in both Orthopaedic and Spinal surgery.

Allovance® Crunch has a clinically proven track record with no incident of any adverse effects or recalls. All Australian Biotechnologies allografts are backed by Australian Research.

Allovance® Fibres/Hybrid/Putty are available for human clinical use. The fibres are processed with Australian Biotechnologies’ PureCleanse technology and available freeze-dried.

For ease of use the freeze-dried Fibres are offered in a graft Xpress delivery device containing fibres only or as a premixed optimum ratio of 50:50 (Allovance® Hybrid) with Allovance® Granules.

Please contact us if you require copies of our catalogues, technical monographs, studies, white papers and case studies.